ArticleBrain communications2026
Blast injury leads to chronic shifts in protein expression of distinct astrocyte populations.
Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blast traumatic brain injury results in chronic pathology, especially for those receiving repetitive injuries. To evaluate cellular changes induced by these pressure waves, we studied post-mortem prefrontal cortex of military personnel with a history of multiple blast exposures and military controls with no battlefield experience. Chronic increases in IBA1 (microglia) and GFAP (glial fibrillary acidic protein; astrocyte) immunoreactivity occurred in injured brains and also confirmed that GFAP-expressing astrocytes altered predominantly at interface regions of the brain: around blood vessels, the grey-white matter interface and in layer 1, consistent with the pattern of damage seen with blast exposure. We focused on pathologic implications of the astrocyte derived proteins GFAP, aquaporin-4, and connexin-43. Astrocyte morphology in injured samples altered significantly, revealing a disintegrated, beaded shape, with a loss of fine processes. We also observed a shift in astrocyte immunoreactivity, where control brains showed two dominant populations, labelling as either GFAP+ or aquaporin-4+ only, with a smaller portion of co-labelled cells. Samples from injured brains revealed the emergence of a third dominant population of cells with abnormal morphology co-labelled with GFAP and aquaporin-4; significant increases in astrocytes with abnormal morphology also occurred, including those both GFAP+ and aquaporin-4+. Connexin-43, which helps maintain neural homeostasis, significantly co-labelled with aquaporin-4, and not GFAP, in both control and injured brains, suggesting the aquaporin-4 subtype to be homeostatic. Interlaminar astrocytes consistently showed abnormal morphology in injured brains, featuring extensive GFAP+ beaded processes. The GFAP+ beaded processes showed additional characteristics in the injured brains, being surrounded in a ring-like fashion by aquaporin-4 immunoreactivity as well as co-labelling with phosphorylated connexin-43, indicating an inflammatory phenotype. To investigate secondary pathology that might relate to immune dysfunction, immunoreactivity with IgG revealed the presence of autoantibody in injury samples, which primarily labelled neurons in layer 2-3 that also co-immunoreacted with complement C3. Half of the interlaminar astrocytes in the injured brains also showed immunoreactivity with C3. We conclude that control human cerebral cortex contains at least two distinct populations that express either GFAP or aquaporin-4, but not both. After military related blast traumatic brain injury, a third population of astrocytes emerges expressing both GFAP and aquaporin-4. Connexin-43 continues to be co-expressed with aquaporin-4, but shifts toward an abnormal morphology. We also find overall chronic alterations in expression of astrocytic proteins that coincide with induction of autoantibodies directed towards neurons and recruit complement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.